Compare KYNB & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYNB | XCUR |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.9M | 26.6M |
| IPO Year | N/A | 2017 |
| Metric | KYNB | XCUR |
|---|---|---|
| Price | $7.16 | $3.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 19.2K | 9.1K |
| Earning Date | 05-11-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.37 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.15 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.32 | $3.10 |
| 52 Week High | $9.58 | $12.65 |
| Indicator | KYNB | XCUR |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 41.34 |
| Support Level | $7.11 | $3.51 |
| Resistance Level | $7.52 | $4.23 |
| Average True Range (ATR) | 0.28 | 0.17 |
| MACD | 0.05 | -0.04 |
| Stochastic Oscillator | 66.09 | 20.00 |
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.